236 related articles for article (PubMed ID: 24205262)
1. Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.
Li S; Wang X; Li Y; Kost CK; Martin DS
PLoS One; 2013; 8(10):e78564. PubMed ID: 24205262
[TBL] [Abstract][Full Text] [Related]
2. Membrane raft redox signalling contributes to endothelial dysfunction and vascular remodelling of thoracic aorta in angiotensin II-infused rats.
Wei J; Xu L; Du YN; Tang XF; Ye MQ; Wu YJ; Han WQ; Gao PJ
Exp Physiol; 2019 Jun; 104(6):946-956. PubMed ID: 30924217
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.
Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V
Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice.
Gao P; Xu TT; Lu J; Li L; Xu J; Hao DL; Chen HZ; Liu DP
J Mol Med (Berl); 2014 Apr; 92(4):347-57. PubMed ID: 24352856
[TBL] [Abstract][Full Text] [Related]
5. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system.
Ludwig A; Fechner M; Wilck N; Meiners S; Grimbo N; Baumann G; Stangl V; Stangl K
J Mol Med (Berl); 2009 Aug; 87(8):793-802. PubMed ID: 19399470
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
Castoldi G; di Gioia CR; Travaglini C; Busca G; Redaelli S; Bombardi C; Stella A
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
[TBL] [Abstract][Full Text] [Related]
8. Sulfur Dioxide Inhibits Extracellular Signal-regulated Kinase Signaling to Attenuate Vascular Smooth Muscle Cell Proliferation in Angiotensin II-induced Hypertensive Mice.
Wu HJ; Huang YQ; Chen QH; Tian XY; Liu J; Tang CS; Jin HF; Du JB
Chin Med J (Engl); 2016 Sep; 129(18):2226-32. PubMed ID: 27625096
[TBL] [Abstract][Full Text] [Related]
9. Differential hypertensive protease expression in the thoracic versus abdominal aorta.
Ruddy JM; Akerman AW; Kimbrough D; Nadeau EK; Stroud RE; Mukherjee R; Ikonomidis JS; Jones JA
J Vasc Surg; 2017 Nov; 66(5):1543-1552. PubMed ID: 28034583
[TBL] [Abstract][Full Text] [Related]
10. Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk.
Huyard F; Yzydorczyk C; Castro MM; Cloutier A; Bertagnolli M; Sartelet H; Germain N; Comte B; Schulz R; DeBlois D; Nuyt AM
PLoS One; 2014; 9(4):e92287. PubMed ID: 24743169
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
Wang Y; Wang L; Zhang F; Zhang C; Deng S; Wang R; Zhang Y; Huang D; Huang K
Int J Cardiol; 2013 Sep; 167(5):2285-93. PubMed ID: 22846599
[TBL] [Abstract][Full Text] [Related]
12. Curcusone D, a novel ubiquitin-proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth.
Cao MN; Zhou YB; Gao AH; Cao JY; Gao LX; Sheng L; Xu L; Su MB; Cao XC; Han MM; Wang MK; Li J
Biochim Biophys Acta; 2014 Jun; 1840(6):2004-13. PubMed ID: 24534329
[TBL] [Abstract][Full Text] [Related]
13. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
[TBL] [Abstract][Full Text] [Related]
14. MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.
Ma Y; Chen B; Liu D; Yang Y; Xiong Z; Zeng J; Dong Y
Biochem Pharmacol; 2011 May; 81(10):1228-36. PubMed ID: 21420391
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation.
Park JW; Qi WN; Cai Y; Urbaniak JR; Chen LE
Plast Reconstr Surg; 2007 Dec; 120(7):1808-1818. PubMed ID: 18090742
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
[TBL] [Abstract][Full Text] [Related]
17. Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation.
Dong H; Ming S; Fang J; Li Y; Liu L
Hum Cell; 2019 Jan; 32(1):22-30. PubMed ID: 30386989
[TBL] [Abstract][Full Text] [Related]
18. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.
Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN
Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
Sun Y; Ramires FJ; Weber KT
Cardiovasc Res; 1997 Jul; 35(1):138-47. PubMed ID: 9302358
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats.
Bach HH; Laporte HM; Wong YM; Gamelli RL; Majetschak M
J Trauma Acute Care Surg; 2013 Feb; 74(2):499-507. PubMed ID: 23354244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
